These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 23263636)
1. Hypoxia-related molecules HIF-1α, CA9, and osteopontin : predictors of survival in patients with high-grade glioma. Erpolat OP; Gocun PU; Akmansu M; Ozgun G; Akyol G Strahlenther Onkol; 2013 Feb; 189(2):147-54. PubMed ID: 23263636 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels. Bache M; Reddemann R; Said HM; Holzhausen HJ; Taubert H; Becker A; Kuhnt T; Hänsgen G; Dunst J; Vordermark D Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1481-7. PubMed ID: 17056190 [TBL] [Abstract][Full Text] [Related]
3. Expression patterns of the hypoxia-related genes osteopontin, CA9, erythropoietin, VEGF and HIF-1alpha in human glioma in vitro and in vivo. Said HM; Hagemann C; Staab A; Stojic J; Kühnel S; Vince GH; Flentje M; Roosen K; Vordermark D Radiother Oncol; 2007 Jun; 83(3):398-405. PubMed ID: 17524506 [TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic and prognostic significance of immunohistochemical expression of HIF-1α, CXCR4 and CA9 in colorectal carcinoma. Saka B; Ekinci O; Dursun A; Akyurek N Pathol Res Pract; 2017 Jul; 213(7):783-792. PubMed ID: 28554753 [TBL] [Abstract][Full Text] [Related]
5. Differential risk assessments from five hypoxia specific assays: The basis for biologically adapted individualized radiotherapy in advanced head and neck cancer patients. Nordsmark M; Eriksen JG; Gebski V; Alsner J; Horsman MR; Overgaard J Radiother Oncol; 2007 Jun; 83(3):389-97. PubMed ID: 17499868 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical detection of HIF-1alpha and CAIX in advanced head-and-neck cancer. Prognostic role and correlation with tumor markers and tumor oxygenation parameters. Kappler M; Taubert H; Holzhausen HJ; Reddemann R; Rot S; Becker A; Kuhnt T; Dellas K; Dunst J; Vordermark D; Hänsgen G; Bache M Strahlenther Onkol; 2008 Aug; 184(8):393-9. PubMed ID: 18956515 [TBL] [Abstract][Full Text] [Related]
7. HIF-1α inhibition by siRNA or chetomin in human malignant glioma cells: effects on hypoxic radioresistance and monitoring via CA9 expression. Kessler J; Hahnel A; Wichmann H; Rot S; Kappler M; Bache M; Vordermark D BMC Cancer; 2010 Nov; 10():605. PubMed ID: 21050481 [TBL] [Abstract][Full Text] [Related]
8. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival. Hui EP; Chan AT; Pezzella F; Turley H; To KF; Poon TC; Zee B; Mo F; Teo PM; Huang DP; Gatter KC; Johnson PJ; Harris AL Clin Cancer Res; 2002 Aug; 8(8):2595-604. PubMed ID: 12171890 [TBL] [Abstract][Full Text] [Related]
9. Cytoplasmic location of factor-inhibiting hypoxia-inducible factor is associated with an enhanced hypoxic response and a shorter survival in invasive breast cancer. Tan EY; Campo L; Han C; Turley H; Pezzella F; Gatter KC; Harris AL; Fox SB Breast Cancer Res; 2007; 9(6):R89. PubMed ID: 18096060 [TBL] [Abstract][Full Text] [Related]
10. Expression of hypoxia-inducible factors is correlated with the presence of a fibrotic focus and angiogenesis in pancreatic ductal adenocarcinomas. Couvelard A; O'Toole D; Leek R; Turley H; Sauvanet A; Degott C; Ruszniewski P; Belghiti J; Harris AL; Gatter K; Pezzella F Histopathology; 2005 Jun; 46(6):668-76. PubMed ID: 15910598 [TBL] [Abstract][Full Text] [Related]
11. Distinct patterns of hypoxic expression of carbonic anhydrase IX (CA IX) in human malignant glioma cell lines. Said HM; Staab A; Hagemann C; Vince GH; Katzer A; Flentje M; Vordermark D J Neurooncol; 2007 Jan; 81(1):27-38. PubMed ID: 16944313 [TBL] [Abstract][Full Text] [Related]
12. Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial. Koukourakis MI; Bentzen SM; Giatromanolaki A; Wilson GD; Daley FM; Saunders MI; Dische S; Sivridis E; Harris AL J Clin Oncol; 2006 Feb; 24(5):727-35. PubMed ID: 16418497 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical markers of the hypoxic response can identify malignancy in phaeochromocytomas and paragangliomas and optimize the detection of tumours with VHL germline mutations. Pinato DJ; Ramachandran R; Toussi ST; Vergine M; Ngo N; Sharma R; Lloyd T; Meeran K; Palazzo F; Martin N; Khoo B; Dina R; Tan TM Br J Cancer; 2013 Feb; 108(2):429-37. PubMed ID: 23257898 [TBL] [Abstract][Full Text] [Related]
14. Prognostic assessment of hypoxia and metabolic markers in cervical cancer using automated digital image analysis of immunohistochemistry. Kim BW; Cho H; Chung JY; Conway C; Ylaya K; Kim JH; Hewitt SM J Transl Med; 2013 Aug; 11():185. PubMed ID: 23927384 [TBL] [Abstract][Full Text] [Related]
15. Vascularization and expression of hypoxia-related tissue factors in intracranial ependymoma and their impact on patient survival. Preusser M; Wolfsberger S; Haberler C; Breitschopf H; Czech T; Slavc I; Harris AL; Acker T; Budka H; Hainfellner JA Acta Neuropathol; 2005 Feb; 109(2):211-6. PubMed ID: 15614581 [TBL] [Abstract][Full Text] [Related]
16. RNA interference targeting hypoxia-inducible factor 1α via a novel multifunctional surfactant attenuates glioma growth in an intracranial mouse model. Gillespie DL; Aguirre MT; Ravichandran S; Leishman LL; Berrondo C; Gamboa JT; Wang L; King R; Wang X; Tan M; Malamas A; Lu ZR; Jensen RL J Neurosurg; 2015 Feb; 122(2):331-41. PubMed ID: 25423275 [TBL] [Abstract][Full Text] [Related]
17. Pancreatic endocrine microadenomatosis in patients with von Hippel-Lindau disease: characterization by VHL/HIF pathway proteins expression. Périgny M; Hammel P; Corcos O; Larochelle O; Giraud S; Richard S; Sauvanet A; Belghiti J; Ruszniewski P; Bedossa P; Couvelard A Am J Surg Pathol; 2009 May; 33(5):739-48. PubMed ID: 19238077 [TBL] [Abstract][Full Text] [Related]
18. Hypoxia inducible factor-1 alpha and carbonic anhydrase IX overexpression are associated with poor survival in breast cancer patients. Kaya AO; Gunel N; Benekli M; Akyurek N; Buyukberber S; Tatli H; Coskun U; Yildiz R; Yaman E; Ozturk B J BUON; 2012; 17(4):663-8. PubMed ID: 23335522 [TBL] [Abstract][Full Text] [Related]
19. Stromal expression of hypoxia regulated proteins is an adverse prognostic factor in colorectal carcinomas. Cleven AH; van Engeland M; Wouters BG; de Bruïne AP Cell Oncol; 2007; 29(3):229-40. PubMed ID: 17452775 [TBL] [Abstract][Full Text] [Related]
20. DNA damage is a prerequisite for p53-mediated proteasomal degradation of HIF-1alpha in hypoxic cells and downregulation of the hypoxia marker carbonic anhydrase IX. Kaluzová M; Kaluz S; Lerman MI; Stanbridge EJ Mol Cell Biol; 2004 Jul; 24(13):5757-66. PubMed ID: 15199132 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]